Stock LSL LSL PHARMA GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

Pharmaceuticals

End-of-day quote Toronto S.E.
Other stock markets
 23:00:00 29/05/2024 BST 		5-day change 1st Jan Change
0.51 CAD -.--% Intraday chart for LSL Pharma Group Inc. +2.00% +5.15%
05-06 LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings MT
05-06 LSL Pharma Group Inc. entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million. CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about LSL Pharma Group Inc.

LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings MT
LSL Pharma Group Inc. entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million. CI
LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units MT
LSL Pharma Group Inc. announced that it has received CAD 6.479426 million in funding from Alfera Pharmaceuticals, LLC CI
LSL Pharma Group Inc. Appoints Diane Beaudry and Mario Paradis to Its Board of Directors CI
LSL Pharma Group Brief: Has Upsized Its Private Placement From $3.5 Million To $7.5 Million MT
LSL Pharma Loses 5% As Raises $6.44 Million In First Closing Of Private Placements MT
LSL Pharma Raises $6.44 Million In First Closing Of Private Placements MT
LSL Pharma Group Inc. announced that it expects to receive CAD 3.5 million in funding CI
LSL Pharma Group Announced An Extension Of Its Convertible Debentures Offering MT
LSL Pharma Group Up 4.7% After Reporting Closing of Second Tranche of Convertible Debentures Offering MT
LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer MT
LSL Pharma Group Inc. Appoints Luc Mainville as Chief Financial Officer, Effective December 4, 2023 CI
LSL Pharma Group Inc. Appoints Luc Mainville as Senior Vice President, Effective December 4, 2023 CI
LSL Pharma Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
LSL Pharma Group Closes First Tranche of Convertible Debentures Offering MT
Groupe LSL Pharma up 10% in Early Trade as Announces New Orders With Annual Revenue Potential of Over $2.6 Million MT
Lsl Laboratory Receives New Orders for Natural Health Products. Unless Otherwise Specified, All Amounts Are in Canadian Dollars CI
LSL Pharma Group Announces Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals MT
LSL Pharma Group Announces Exclusive Distribution Agreement with Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals CI
LSL Pharma Group Plans Brokered Private Placement of Convertible Debentures MT
LSL Pharma Group Inc. announced that it expects to receive $4 million in funding CI
LSL Pharma Group Inc. Announces Executive Changes, Effective August 31, 2023 CI
LSL Pharma Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
LSL Pharma Group Expects Increase in Production Capacity, Sales Growth MT

Chart LSL Pharma Group Inc.

Chart LSL Pharma Group Inc.
More charts

Company Profile

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company’s subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.
Sector
Pharmaceuticals
Calendar
27/06/2024 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

1st Jan change Capi.
LSL PHARMA GROUP INC. Stock LSL Pharma Group Inc.
+5.15% 40.46M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LSL Stock
  4. News LSL Pharma Group Inc.
  5. LSL Pharma Group Up 4.7% After Reporting Closing of Second Tranche of Convertible Debentures Offering